1. Home
  2. ONCY vs ARAY Comparison

ONCY vs ARAY Comparison

Compare ONCY & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$1.12

Market Cap

94.0M

Sector

Health Care

ML Signal

HOLD

Logo Accuray Incorporated

ARAY

Accuray Incorporated

HOLD

Current Price

$0.79

Market Cap

100.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONCY
ARAY
Founded
1998
1990
Country
Canada
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
94.0M
100.5M
IPO Year
1999
2007

Fundamental Metrics

Financial Performance
Metric
ONCY
ARAY
Price
$1.12
$0.79
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
2
Target Price
$6.00
$4.50
AVG Volume (30 Days)
1.2M
719.5K
Earning Date
03-06-2026
02-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$450,902,000.00
Revenue This Year
N/A
$3.82
Revenue Next Year
N/A
$4.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.51
52 Week Low
$0.33
$0.78
52 Week High
$1.51
$2.95

Technical Indicators

Market Signals
Indicator
ONCY
ARAY
Relative Strength Index (RSI) 54.97 35.93
Support Level $0.98 $0.79
Resistance Level $1.30 $0.86
Average True Range (ATR) 0.09 0.05
MACD 0.02 0.00
Stochastic Oscillator 52.63 3.67

Price Performance

Historical Comparison
ONCY
ARAY

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

About ARAY Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

Share on Social Networks: